07.10.25 -- STREAM Edition: Microbial Expression Versus Chemical Synthesis In Peptide Production

Gain insights pertinent to efficient and effective drug development. Understand and execute a risked-based critical thinking approach related to injectable drug packaging and delivery.

Learn how to select an experienced nitrosamine mitigation provider and how a tailored, quantified strategy can help you bring your product into compliance while maintaining control of the process.

In this segment of the Pharmaceutical Online Live event, our panelists weigh in on when to use microbial expression versus synthetic chemistry for peptide production.

Panelists explore the entire patient journey, from diagnosis to treatment, sharing strategies for creating practical, seamless support systems that ensure access to innovative cell and gene therapies.

Discover a strategic approach to accelerating biologics formulation by gaining early insight into molecular properties and optimizing high-concentration conditions with minimal protein input.

Uncover a cutting-edge syringe liquid sampler for Life Sciences that offers USP <788> compliance, versatile syringe compatibility, and advanced features for precise particulate testing.